{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:13:18Z","timestamp":1766067198780,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41375-020-01017-z","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T16:04:42Z","timestamp":1597853082000},"page":"1193-1196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of upfront chemotherapy on overall survival in isolated myeloid sarcoma"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0216-3818","authenticated-orcid":false,"given":"Konstantinos","family":"Lontos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan G.","family":"Yabes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafic J.","family":"Farah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6699-6355","authenticated-orcid":false,"given":"Michael","family":"Boyiadzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"1017_CR1","unstructured":"Swerdlow SCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition). Lyon: IARC; 2017."},{"key":"1017_CR2","first-page":"333","volume":"153","author":"JC Dalland","year":"2020","unstructured":"Dalland JC, Meyer R, Ketterling RP, Reichard KK. Myeloid sarcoma with CBFB-MYH11 Fusion (inv(16) or t(16;16)) prevails in the abdomen. Am J Clin Pathol. 2020;153:333\u201341.","journal-title":"Am J Clin Pathol"},{"key":"1017_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/ejh.13056","volume":"100","author":"H Claerhout","year":"2018","unstructured":"Claerhout H, Van Aelst S, Melis C, Tousseyn T, Gheysens O, Vandenberghe P, et al. Clinicopathological characteristics of de novo and secondary myeloid sarcoma: a monocentric retrospective study. Eur J Haematol. 2018;100:603\u201312.","journal-title":"Eur J Haematol"},{"key":"1017_CR4","unstructured":"National Comprehensive Cancer Network. Acute myeloid leukemia (version 3.2020). National Comprehensive Cancer Network. 2019; https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf."},{"key":"1017_CR5","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1200\/JCO.2011.35.7525","volume":"29","author":"RB Walter","year":"2011","unstructured":"Walter RB, Othus M, Borthakur G, Ravandi F, Cortes JE, Pierce SA, et al. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol. 2011;29:4417\u201323.","journal-title":"J Clin Oncol"},{"key":"1017_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12561-016-9157-9","volume":"9","author":"H Putter","year":"2017","unstructured":"Putter H, van Houwelingen HC. Understanding landmarking and its relation with time-dependent Cox regression. Stat Biosci. 2017;9:489\u2013503.","journal-title":"Stat Biosci"},{"key":"1017_CR7","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/cncr.10399","volume":"94","author":"K Yamauchi","year":"2002","unstructured":"Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94:1739\u201346.","journal-title":"Cancer."},{"key":"1017_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/COC.0b013e3181dea934","volume":"34","author":"MM Byrne","year":"2011","unstructured":"Byrne MM, Halman LJ, Koniaris LG, Cassileth PA, Rosenblatt JD, Cheung MC. Effects of poverty and race on outcomes in acute myeloid leukemia. Am J Clin Oncol. 2011;34:297\u2013304.","journal-title":"Am J Clin Oncol"},{"key":"1017_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cmpb.2003.10.004","volume":"75","author":"SR Cole","year":"2004","unstructured":"Cole SR, Hernan MA. Adjusted survival curves with inverse probability weights. Comput Methods Prog Biomed. 2004;75:45\u20139.","journal-title":"Comput Methods Prog Biomed"},{"key":"1017_CR10","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/sim.2174","volume":"24","author":"J Xie","year":"2005","unstructured":"Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med. 2005;24:3089\u2013110.","journal-title":"Stat Med."},{"key":"1017_CR11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","volume":"84","author":"DWLJ Lin","year":"1989","unstructured":"Lin DWLJ. The robust inference for the proportional hazards model. J Am Stat Assoc. 1989;84:1074\u20138.","journal-title":"J Am Stat Assoc."},{"key":"1017_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268\u201374.","journal-title":"Ann Intern Med"},{"key":"1017_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.7326\/0003-4819-123-5-199509010-00005","volume":"123","author":"KR Imrie","year":"1995","unstructured":"Imrie KR, Kovacs MJ, Selby D, Lipton J, Patterson BJ, Pantalony D, et al. Isolated chloroma: the effect of early antileukemic therapy. Ann Intern Med. 1995;123:351\u20133.","journal-title":"Ann Intern Med"},{"key":"1017_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.79","volume":"7","author":"G Goyal","year":"2017","unstructured":"Goyal G, Bartley AC, Patnaik MM, Litzow MR, Al-Kali A, Go RS. Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set. Blood Cancer J. 2017;7:e592.","journal-title":"Blood Cancer J."},{"key":"1017_CR15","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/sj.leu.2402958","volume":"17","author":"AM Tsimberidou","year":"2003","unstructured":"Tsimberidou AM, Kantarjian HM, Estey E, Cortes JE, Verstovsek S, Faderl S, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia. 2003;17:1100\u20133.","journal-title":"Leukemia."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-01017-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-01017-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-01017-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T23:03:58Z","timestamp":1629327838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-01017-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1017"],"URL":"https:\/\/doi.org\/10.1038\/s41375-020-01017-z","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"type":"print","value":"0887-6924"},{"type":"electronic","value":"1476-5551"}],"subject":[],"published":{"date-parts":[[2020,8,19]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}